SAN FRANCISCO, California and VANCOUVER, Canada, June 2, 2022
/PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company")
(NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on
developing novel therapies for the treatment of prostate cancer,
today announced that the Company will be presenting at the 2022
Jefferies Healthcare Conference in New
York City on Thursday, June 9,
2022 at 3:00 p.m. Eastern
David. R. Parkinson, President and Chief Executive Officer of
ESSA Pharma, will participate in and host one-on-one meetings.
David S. Wood, ESSA's Chief
Financial Officer, will also be participating in the one-on-one
Thursday, June 9,
3:00 p.m. ET
About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on
developing novel and proprietary therapies for the treatment of
patients with prostate cancer. For more information, please visit
www.essapharma.com and follow us on Twitter under @ESSAPharma.
A webcast of the presentation can be accessed in the
Investors/Events & Presentations section of ESSA's website at
www.essapharma.com. Following the presentation, the webcast will be
archived for 90 days.
SOURCE ESSA Pharma Inc